These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 26540241

  • 21. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
    Merigo E, Manfredi M, Meleti M, Guidotti R, Ripasarti A, Zanzucchi E, D'Aleo P, Corradi D, Corcione L, Sesenna E, Ferrari S, Poli T, Bonaninil M, Vescovi P.
    Acta Biomed; 2006 Aug; 77(2):109-17. PubMed ID: 17172192
    [Abstract] [Full Text] [Related]

  • 22. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
    Fitzpatrick SG, Stavropoulos MF, Bowers LM, Neuman AN, Hinkson DW, Green JG, Bhattacharyya I, Cohen DM.
    J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
    [No Abstract] [Full Text] [Related]

  • 23. Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature.
    Kreutle V, Blum C, Meier C, Past M, Müller B, Schütz P, Borm K.
    Swiss Med Wkly; 2014 Feb; 144():w13979. PubMed ID: 24964073
    [Abstract] [Full Text] [Related]

  • 24. Two cases of drug-induced orbital inflammatory disease.
    Ortiz-Perez S, Fernandez E, Molina JJ, Sanchez-Dalmau B, Navarro M, Corretger X, Olver JM.
    Orbit; 2011 Jan; 30(1):37-9. PubMed ID: 21281079
    [Abstract] [Full Text] [Related]

  • 25. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I, Magopoulos C, Karakasis D.
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [Abstract] [Full Text] [Related]

  • 26. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
    Ringe JD.
    MMW Fortschr Med; 2009 Mar 05; 151(10):7. PubMed ID: 19472655
    [No Abstract] [Full Text] [Related]

  • 27. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases.
    Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC.
    Am J Otolaryngol; 2009 Mar 05; 30(6):390-5. PubMed ID: 19880027
    [Abstract] [Full Text] [Related]

  • 28. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS, Lo JC.
    J Oral Maxillofac Surg; 2012 Aug 05; 70(8):1844-53. PubMed ID: 22595135
    [Abstract] [Full Text] [Related]

  • 29. Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature.
    Pechalova P, Bakardjiev A, Zaprianov Z, Vladimirov B, Poriazova E, Zheleva A, Hadjigeorgiev G, Goranova-Marinova V, Goranov S.
    Acta Clin Croat; 2011 Jun 05; 50(2):273-9. PubMed ID: 22263396
    [Abstract] [Full Text] [Related]

  • 30. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
    Voss PJ, Joshi Oshero J, Kovalova-Müller A, Veigel Merino EA, Sauerbier S, Al-Jamali J, Lemound J, Metzger MC, Schmelzeisen R.
    J Craniomaxillofac Surg; 2012 Dec 05; 40(8):719-25. PubMed ID: 22336489
    [Abstract] [Full Text] [Related]

  • 31. Another case of bisphosphonate-induced orbital inflammation.
    Yang EB, Birkholz ES, Lee AG.
    J Neuroophthalmol; 2010 Mar 05; 30(1):94-5. PubMed ID: 20182217
    [No Abstract] [Full Text] [Related]

  • 32. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder.
    Dannemann C, Grätz KW, Riener MO, Zwahlen RA.
    Bone; 2007 Apr 05; 40(4):828-34. PubMed ID: 17236837
    [Abstract] [Full Text] [Related]

  • 33. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov 05; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 34. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    French DD, Margo CE.
    Retina; 2008 Jun 05; 28(6):889-93. PubMed ID: 18536608
    [Abstract] [Full Text] [Related]

  • 35. Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.
    Lobato JV, Maurício AC, Rodrigues JM, Cavaleiro MV, Cortez PP, Xavier L, Botelho C, Hussain NS, Santos JD.
    J Plast Reconstr Aesthet Surg; 2008 Jun 05; 61(1):99-106. PubMed ID: 18068658
    [Abstract] [Full Text] [Related]

  • 36. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.
    Leite AF, Figueiredo PT, Melo NS, Acevedo AC, Cavalcanti MG, Paula LM, Paula AP, Guerra EN.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul 05; 102(1):14-21. PubMed ID: 16831667
    [Abstract] [Full Text] [Related]

  • 37. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
    Wongchuensoontorn C, Liebehenschel N, Wagner K, Fakler O, Gutwald R, Schmelzeisen R, Sauerbier S.
    J Oral Maxillofac Surg; 2009 Jun 05; 67(6):1311-6. PubMed ID: 19446222
    [No Abstract] [Full Text] [Related]

  • 38. Bisphosphonate-related osteonecrosis of the jaws--a case report.
    Kamoh AK, Ogle O.
    Compend Contin Educ Dent; 2012 May 05; 33(5):e74-7. PubMed ID: 23268588
    [Abstract] [Full Text] [Related]

  • 39. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb 05; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 40. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Udvardy E, Redl P, Márton I.
    Magy Onkol; 2008 Mar 05; 52(1):81-7. PubMed ID: 18403302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.